Treatment guidelines: latest news

Treatment guidelines resources

  • When to start treatment

    Until recently, doctors weren’t sure of the best time to start HIV treatment. However in 2015 a large, well-conducted study demonstrated that there are advantages to starting...

    From: Booklets

    Information level Level 2
  • HIV treatment as prevention

    This briefing paper, produced by NAM for HIV Prevention England, describes the scientific evidence for HIV treatment as prevention and considers its implications for the UK....

    From: HIV prevention briefing papers

Treatment guidelines features

Treatment guidelines news from aidsmap

More news

Treatment guidelines news selected from other sources

  • Gay New Zealand welcomes removal of HIV meds restriction

    The decision of New Zealand's drug regulator Pharmac to remove a restriction on when people newly-diagnosed with HIV can be put on medications will "significantly benefit people newly diagnosed with HIV and those living with HIV as well as efforts to prevent HIV transmission” according to the NZ AIDS Foundation. “New Zealand is one of few countries in the developed world to still have a restriction on treatment access,” the NZAF's Executive Director Jason Myers says. “Early treatment is a fundamental pillar of NZAFs Ending HIV programme."

    08 May 2017 | Gay New Zealand
  • Should Antiretroviral Therapy be Offered the Same Day as Diagnosis?

    Andy Seale summarizes a discussion that took place on ITPC’s listserv about when to initiate antiretroviral therapy. The discussion included consideration of WHO’s recommendation for Same Day Start.

    23 March 2017 | ITPC
  • Advanced HIV disease & Same day start of ART - Make your voice heard!

    The World Health Organization is seeking the values & preferences of people living with HIV as it prepares new guidelines on two topics: whether ART should be started on the same day of a diagnosis of HIV, and the best combination of treatment for people living with HIV who look for care when they already have advanced HIV disease. Deadline: this Sunday, 19 March 2017.

    14 March 2017 | WHO
  • Clinical Commissioning Policy: Tenofovir Alafenamide for treatment of HIV 1 in adults and adolescents

    TAF containing products can be made available to patients who have defined renal or bone problems or who have medical reasons why they cannot take other HIV drugs.

    06 March 2017 | NHS England
  • From Twitter To Treatment Guidelines, Industry Influence Permeates Medicine

    The long arm of the pharmaceutical industry continues to pervade practically every area of medicine, reaching those who write guidelines that shape doctors' practices, patient advocacy organizations, letter writers to the Centers for Disease Control and Prevention and even oncologists on Twitter, according to a series of papers on money and influence published Tuesday in JAMA Internal Medicine.

    18 January 2017 | NPR
  • Kiwi HIV patients 'denied access to medication'

    The New Zealand AIDS Foundation (NZAF) says Kiwis with newly diagnosed HIV infections are being unfairly penalised by outdated policies denying them access to important medication. Currently people diagnosed with HIV in New Zealand cannot access medication until their CD4 cell (white blood cell) count has dropped below 500.

    24 November 2016 | Newshub
  • UNITAID and ANRS launch initiative in Cameroon to bring new HIV treatments to Africa

    A study launched in Yaoundé will test the latest generation of HIV treatment based on Dolutegravir under local conditions, with a view to establishing its viability in Africa. The results of the study are intended to inform the World Health Organization’s guidelines for the treatment of HIV patients in Africa. If successful, they will help to accelerate the opening of the market for these combinations to manufacturers of generic medicines and thereby reduce prices as well as improve access.

    17 November 2016 | UNITAID
  • Why 2.1 million Indians infected with HIV do not get the drugs they need

    Each of an estimated 2.1 million Indians infected with the human immunodeficiency virus (HIV) should be getting a cocktail of drugs to prolong their lives and reduce infections, but no more than 44% do, the minister of health told the Lok Sabha (parliament’s lower house) in April 2016.

    12 September 2016 | Firstpost
  • South Africa: ARVS now easier to get

    From today anyone who is HIV- positive can access ARVs from a state facility - good news for about 4million people living with the virus but not on medication. Until now only HIV-positive but people with CD4 counts lower than 500 (the measure of immune system strength) qualified for treatment under the Department of Health's treatment guidelines

    01 September 2016 | TIMES Live
  • Zimbabwe: All HIV+ Patients to Get ARVs

    All people who tested positive to HIV from Manicaland and Matabeleland South provinces in June will immediately be placed on antiretroviral therapy regardless of their CD4 count as the country seeks to operationalise the latest World Health Organisation guidelines on treatment and care of HIV.

    30 August 2016 | AllAfrica
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.

See also

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.